A randomized Phase II clinical trial confirmed that the triple therapy combination of an anti-PD-1 antibody (Sintilimab), an HDAC inhibitor (Citarinostat), and an anti-VEGF antibody (Bevacizumab) demonstrated significant clinical efficacy in colorectal cancer
By purchasing this product, the buyer acknowledges that the material will be used only for lawful laboratory research purposes
Ginsenoside rg1 regulates liver lipid factor metabolism in nafld model rats
Journal of the American College of Nutrition , 18, 1, 01-02-1999, p
& Formulated with botanical proteins and Niacinamide, this serum targets rough, uneven skin caused by past breakouts
However, caffeine did not modify the vascular response to vasoconstrictors in splanchnic, hepatic, and collateral vascular beds in this study, although the specific reasons for this remain to be determined (Hsu et al., 2015)